Xponentia extends PE funding to In Vitro Diagnostics firm Medsource Ozone
Advertisement

Xponentia extends PE funding to In Vitro Diagnostics firm Medsource Ozone

By Joseph Rai

  • 12 Jan 2022
Premium
Xponentia extends PE funding to In Vitro Diagnostics firm Medsource Ozone
Credit: Pexels

Xponentia Capital has invested in an In Vitro Diagnostics (IVD) manufacturer Medsource Ozone Biomedicals Pvt. Ltd, a top executive at the private equity (PE) firm told VCCircle.  This investment in Medsouce was made from the PE firm’s first fund -- Xponentia Opportunities Fund-1, and this is its fourth deal in the ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.
Advertisement
Advertisement
Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News